AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33719164 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative cell salvage and autotransfusion (ICSA)
Number of subjects: 0
Study 33719164 — intervention group
Group type: COMPARATOR
Intervention: Control group (without ICSA)
Number of subjects: 0
Study 32776828 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone enanthate 200 mg/week (TEST)
Number of subjects: 50
Study 32776828 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 50
Study 32776828 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone enanthate (TEST)
Number of subjects: 50
Study 35101120 — intervention group
Group type: EXPERIMENTAL
Intervention: Bankart repair + Remplissage
Number of subjects: 82
Study 35101120 — intervention group
Group type: COMPARATOR
Intervention: Latarjet procedure
Number of subjects: 82
Study 33106629 — intervention group
Group type: EXPERIMENTAL
Intervention: left prefrontal cortex anodal transcranial direct current stimulation (tDCS) with decision‐making training
Number of subjects: 133
Study 33106629 — intervention group
Group type: COMPARATOR
Intervention: control groups (three control groups)
Number of subjects: 133
Study 34819329 — intervention group
Group type: EXPERIMENTAL
Intervention: PEP flute self-care
Number of subjects: 378
Study 34819329 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 378
Study 33239870 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel Muscle Training Device (NMT)
Number of subjects: 32
Study 33239870 — intervention group
Group type: COMPARATOR
Intervention: Conventional Rehabilitation Training (CRT)
Number of subjects: 32
Study 33273042 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy with metformin, pioglitazone, and exenatide
Number of subjects: 318
Study 33273042 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy with sequential addition of metformin, glipizide, and insulin
Number of subjects: 318
Study 33273042 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy
Number of subjects: 318
Study 33273042 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 318
Study 33228572 — intervention group
Group type: EXPERIMENTAL
Intervention: MINISTOP 2.0 app (6-month parent-oriented smartphone intervention)
Number of subjects: 500
Study 33228572 — intervention group
Group type: COMPARATOR
Intervention: Routine child health care (Control)
Number of subjects: 500
Study 35768027 — intervention group
Group type: EXPERIMENTAL
Intervention: Urologists' recommendations (79% surgery)
Number of subjects: 108
Study 35768027 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation oncologists' recommendations (68% radiation)
Number of subjects: 108
Study 35768027 — intervention group
Group type: EXPERIMENTAL
Intervention: Discordant recommendations (urologists recommended surgery, radiation oncologists recommended radiation and surgery as equally appropriate)
Number of subjects: 108
Study 32506088 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection paracetamol (1gm) and 0.25% bupivacaine (total 20ml) in scalp block
Number of subjects: 40
Study 32506088 — intervention group
Group type: COMPARATOR
Intervention: 100ml normal saline infusion and 0.25% bupivacaine (20ml) in scalp block
Number of subjects: 40
Study 34428254 — intervention group
Group type: EXPERIMENTAL
Intervention: Default nudge (affirmative answer pre-selected)
Number of subjects: 1227
Study 34428254 — intervention group
Group type: EXPERIMENTAL
Intervention: Social norm nudge (stated that most people answered affirmative)
Number of subjects: 1227
Study 34428254 — intervention group
Group type: EXPERIMENTAL
Intervention: Default nudge (in actual choice setting)
Number of subjects: 1227
Study 34428254 — intervention group
Group type: EXPERIMENTAL
Intervention: Default nudge with explanation
Number of subjects: 1227
Study 34428254 — intervention group
Group type: EXPERIMENTAL
Intervention: Nudged (actual choice setting)
Number of subjects: 1227
Study 34428254 — intervention group
Group type: COMPARATOR
Intervention: Control (no nudge)
Number of subjects: 1227
Study 32358504 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood cis-eGenes identified through Mendelian randomization (MR)
Number of subjects: 31684
Study 32358504 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood eGenes enriched in dendritic cells (DCs)
Number of subjects: 31684
Study 32358504 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis
Number of subjects: 31684
Study 33484138 — intervention group
Group type: EXPERIMENTAL
Intervention: 0 risk factors present
Number of subjects: 130
Study 33484138 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 risk factor present
Number of subjects: 130
Study 33484138 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 or more risk factors present
Number of subjects: 130
Study 34286416 — intervention group
Group type: EXPERIMENTAL
Intervention: Interviewer-led telephone administration of EORTC QLQ-C30
Number of subjects: 63
Study 34286416 — intervention group
Group type: COMPARATOR
Intervention: Paper first administration of EORTC QLQ-C30
Number of subjects: 63
Study 34286416 — intervention group
Group type: COMPARATOR
Intervention: Phone first administration of EORTC QLQ-C30
Number of subjects: 63
Study 32307560 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of methylphenidate (N=29)
Number of subjects: 60
Study 32307560 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N=31)
Number of subjects: 60
Study 35928033 — intervention group
Group type: EXPERIMENTAL
Intervention: PfSPZ-CVac (CQ)
Number of subjects: 62
Study 35928033 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 62
Study 32428840 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoenergetic diet with 12 hours of fasting daily
Number of subjects: 58
Study 32428840 — intervention group
Group type: COMPARATOR
Intervention: Hypoenergetic diet only
Number of subjects: 58
Study 34196698 — intervention group
Group type: EXPERIMENTAL
Intervention: M1-rTMS
Number of subjects: 152
Study 34196698 — intervention group
Group type: EXPERIMENTAL
Intervention: DLPFC-rTMS
Number of subjects: 152
Study 34196698 — intervention group
Group type: COMPARATOR
Intervention: Sham-rTMS
Number of subjects: 152
Study 32126576 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-guided coil embolization and cyanoacrylate injection
Number of subjects: 60
Study 32126576 — intervention group
Group type: COMPARATOR
Intervention: EUS-guided coil embolization alone
Number of subjects: 60
Study 36368940 — intervention group
Group type: EXPERIMENTAL
Intervention: PcV 800 mg × 4 for 5 days
Number of subjects: 433
Study 36368940 — intervention group
Group type: COMPARATOR
Intervention: PcV 1 g × 3 for 10 days
Number of subjects: 433
Study 34074585 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 0
Study 34074585 — intervention group
Group type: COMPARATOR
Intervention: Tocilizumab
Number of subjects: 0
Study 34074585 — intervention group
Group type: COMPARATOR
Intervention: Baricitinib
Number of subjects: 0
Study 34074585 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 0
Study 32375100 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart Moms intervention (mobile phone-based program)
Number of subjects: 51
Study 32375100 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 51
Study 35193654 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine (3000 mg/day for 7 days)
Number of subjects: 60
Study 35193654 — intervention group
Group type: COMPARATOR
Intervention: Placebo (same dosage and duration as L-carnitine)
Number of subjects: 60
Study 32918899 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxic air (Fio2, 15%)
Number of subjects: 28
Study 32918899 — intervention group
Group type: COMPARATOR
Intervention: Ambient air (normoxia; Fio2, 21%)
Number of subjects: 28
Study 34908227 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-based peanut paste
Number of subjects: 80
Study 34908227 — intervention group
Group type: EXPERIMENTAL
Intervention: Biscuit
Number of subjects: 80
Study 34908227 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 80
Study 34147150 — intervention group
Group type: EXPERIMENTAL
Intervention: Obeticholic acid
Number of subjects: 0
Study 34147150 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32723163 — intervention group
Group type: EXPERIMENTAL
Intervention: Falls in the past year
Number of subjects: 966
Study 32723163 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous falls
Number of subjects: 966
Study 32723163 — intervention group
Group type: EXPERIMENTAL
Intervention: Accidental falls
Number of subjects: 966
Study 32723163 — intervention group
Group type: EXPERIMENTAL
Intervention: Time of falls
Number of subjects: 966
Study 32723163 — intervention group
Group type: EXPERIMENTAL
Intervention: Season of falls
Number of subjects: 966
Study 32723163 — intervention group
Group type: EXPERIMENTAL
Intervention: Falling flat on the ground
Number of subjects: 966
Study 32723163 — intervention group
Group type: EXPERIMENTAL
Intervention: Fall location
Number of subjects: 966
Study 32723163 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of an object favoring the fall
Number of subjects: 966
Study 32723163 — intervention group
Group type: EXPERIMENTAL
Intervention: Floor conditions
Number of subjects: 966
Study 32723163 — intervention group
Group type: EXPERIMENTAL
Intervention: Type of footwear
Number of subjects: 966
Study 32723163 — intervention group
Group type: EXPERIMENTAL
Intervention: Need for assistance to get up
Number of subjects: 966
Study 34536308 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance therapy with carfilzomib (27-56 mg/sqm) and dexamethasone (20 mg every second week)
Number of subjects: 200
Study 34536308 — intervention group
Group type: COMPARATOR
Intervention: Observation (control group)
Number of subjects: 200
Study 33662112 — intervention group
Group type: EXPERIMENTAL
Intervention: Overminus spectacle therapy (‐2.50 D for 12 months, then ‐1.25 D for 3 months, followed by nonoverminus spectacles for 3 months)
Number of subjects: 386
Study 33662112 — intervention group
Group type: COMPARATOR
Intervention: Nonoverminus spectacle use
Number of subjects: 386
Study 33321842 — intervention group
Group type: EXPERIMENTAL
Intervention: EC-based alignment using a motion detection based approach with cascaded regression of extremely randomized trees.
Number of subjects: 0
Study 33321842 — intervention group
Group type: COMPARATOR
Intervention: Annotator disagreement in face pose alignment.
Number of subjects: 0
Study 34420187 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 150
Study 34420187 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 32418064 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis-induced hallucinated breakfast (HB)
Number of subjects: 8
Study 32418064 — intervention group
Group type: COMPARATOR
Intervention: Real breakfast (RB)
Number of subjects: 8
Study 35710428 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes mobile application
Number of subjects: 180
Study 35710428 — intervention group
Group type: COMPARATOR
Intervention: Current standard care
Number of subjects: 180
Study 35467300 — intervention group
Group type: EXPERIMENTAL
Intervention: ω‐3 fatty acid immunonutritional therapy
Number of subjects: 70
Study 33939973 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised physical exercise twice a week
Number of subjects: 121
Study 33939973 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 121
Study 32820744 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to audiology services
Number of subjects: 6432
Study 32820744 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing loss
Number of subjects: 6432
Study 33724668 — intervention group
Group type: EXPERIMENTAL
Intervention: Loop-tail stents (Polaris™ Loop)
Number of subjects: 68
Study 33724668 — intervention group
Group type: COMPARATOR
Intervention: Conventional double J stents (Vortek®)
Number of subjects: 68
Study 34538755 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebilustat 50 mg
Number of subjects: 199
Study 34538755 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebilustat 100 mg
Number of subjects: 199
Study 34538755 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study 34538755 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebilustat (both doses)
Number of subjects: 199
Study 35513562 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone electrocardiogram (AliveCor Kardia) used 5 times/week
Number of subjects: 100
Study 35513562 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 100
Study 35130231 — intervention group
Group type: EXPERIMENTAL
Intervention: Otoscopic findings
Number of subjects: 203
Study 35130231 — intervention group
Group type: COMPARATOR
Intervention: Tympanometric impedance measurement
Number of subjects: 203
Study 34260519 — intervention group
Group type: EXPERIMENTAL
Intervention: Jinfukang
Number of subjects: 168
Study 34260519 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study 33066773 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-centered behavioral and educational counselling program
Number of subjects: 589
Study 33066773 — intervention group
Group type: COMPARATOR
Intervention: OHE pamphlets (control group)
Number of subjects: 589
Study 33066773 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 589
Study 34145078 — intervention group
Group type: EXPERIMENTAL
Intervention: Health check programme (IG)
Number of subjects: 10505
Study 33330983 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2%
Number of subjects: 69
Study 33330983 — intervention group
Group type: COMPARATOR
Intervention: NaCl 0.9% (placebo)
Number of subjects: 69
Study 32865373 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab (420 mg monthly subcutaneous injections)
Number of subjects: 157
Study 32865373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study 32865373 — intervention group
Group type: COMPARATOR
Intervention: Evolocumab and Placebo
Number of subjects: 157
Study 34551415 — intervention group
Group type: EXPERIMENTAL
Intervention: Active left rTMS
Number of subjects: 46
Study 34551415 — intervention group
Group type: EXPERIMENTAL
Intervention: Active right rTMS
Number of subjects: 46
Study 34551415 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 46
Study 33617942 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass Hybrid (GH) - EQUIA Forte, GC
Number of subjects: 180
Study 33617942 — intervention group
Group type: COMPARATOR
Intervention: Composite (CO) - TetricEvoCeram, IvoclarVivadent
Number of subjects: 180
Study 32303373 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand sanitizer group (HSG); n=339
Number of subjects: 911
Study 32303373 — intervention group
Group type: EXPERIMENTAL
Intervention: Soap and water group; n=274
Number of subjects: 911
Study 32303373 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG); n=298
Number of subjects: 911
Study 32460658 — intervention group
Group type: EXPERIMENTAL
Intervention: Victimization salience: yes (reminded of a previous victimization experience)
Number of subjects: 181
Study 32460658 — intervention group
Group type: COMPARATOR
Intervention: Victimization salience: no (not reminded of a previous victimization experience)
Number of subjects: 181
Study 32511829 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive Movement (PM)
Number of subjects: 20
Study 32511829 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction (BFR)
Number of subjects: 20
Study 32511829 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive Movement + Blood Flow Restriction (PM + BFR)
Number of subjects: 20
Study 32511829 — intervention group
Group type: COMPARATOR
Intervention: Time Control (TC)
Number of subjects: 20
Study 36113007 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound betamethasone
Number of subjects: 38
Study 36113007 — intervention group
Group type: COMPARATOR
Intervention: Control (no compound betamethasone)
Number of subjects: 38
Study 34036457 — intervention group
Group type: EXPERIMENTAL
Intervention: Infertility labeled as 'disease'
Number of subjects: 1226
Study 34036457 — intervention group
Group type: EXPERIMENTAL
Intervention: Infertility labeled as 'disability'
Number of subjects: 1226
Study 34036457 — intervention group
Group type: COMPARATOR
Intervention: Infertility labeled as 'condition'
Number of subjects: 1226
Study 34176610 — intervention group
Group type: EXPERIMENTAL
Intervention: Action stage
Number of subjects: 98
Study 34176610 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance stage (parents)
Number of subjects: 98
Study 34176610 — intervention group
Group type: EXPERIMENTAL
Intervention: Action stage (parents)
Number of subjects: 98
Study 34057298 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoe-stiffening inserts
Number of subjects: 48
Study 34057298 — intervention group
Group type: COMPARATOR
Intervention: Sham inserts
Number of subjects: 48
Study 34057298 — intervention group
Group type: COMPARATOR
Intervention: Shoe only (control)
Number of subjects: 48
Study 34255009 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma injection
Number of subjects: 240
Study 34255009 — intervention group
Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 240
Study 36121729 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel polymeric nanoparticle gel
Number of subjects: 80
Study 36121729 — intervention group
Group type: COMPARATOR
Intervention: Commercial gel (Opalescence PF)
Number of subjects: 80
Study 32820846 — intervention group
Group type: EXPERIMENTAL
Intervention: WT - whitening toothpaste
Number of subjects: 75
Study 32820846 — intervention group
Group type: COMPARATOR
Intervention: CT - conventional toothpaste
Number of subjects: 75
Study 32820846 — intervention group
Group type: EXPERIMENTAL
Intervention: CP10 - 10% carbamide peroxide
Number of subjects: 75
Study 34488379 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component exercise training
Number of subjects: 90
Study 34488379 — intervention group
Group type: COMPARATOR
Intervention: General community health instruction
Number of subjects: 90
Study 34312883 — intervention group
Group type: EXPERIMENTAL
Intervention: Fostering Healthy Futures program (FHF), a 9-month one-to-one mentoring and skills group intervention
Number of subjects: 426
Study 34312883 — intervention group
Group type: EXPERIMENTAL
Intervention: Fostering Healthy Futures program (FHF)
Number of subjects: 426
Study 34546534 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD5718 (60 mg)
Number of subjects: 32
Study 34546534 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD5718 (180 mg)
Number of subjects: 32
Study 34546534 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD5718 (360 mg)
Number of subjects: 32
Study 34546534 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD5718 (600 mg)
Number of subjects: 32
Study 34546534 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 34751888 — intervention group
Group type: EXPERIMENTAL
Intervention: Nuestras Familias: Andando Entre Culturas (culturally adapted evidence-based parent management training)
Number of subjects: 241
Study 34751888 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 241
Study 34493958 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT protocol 4×4
Number of subjects: 10
Study 34493958 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT protocol 10-20-30
Number of subjects: 10
Study 34493958 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT protocol 6×1
Number of subjects: 10
Study 36440782 — intervention group
Group type: EXPERIMENTAL
Intervention: Relatox injections
Number of subjects: 180
Study 36440782 — intervention group
Group type: COMPARATOR
Intervention: Botox injections
Number of subjects: 180
Study 36440782 — intervention group
Group type: COMPARATOR
Intervention: Relatox and Botox (both groups)
Number of subjects: 180
Study 33805025 — intervention group
Group type: EXPERIMENTAL
Intervention: Active play intervention (≥2 children jumping together for approximately 10 s per session, at least five times a day, approximately 1 min/day)
Number of subjects: 0
Study 33805025 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study 36060670 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated medical and nursing rounds combined with AIDET communication mode
Number of subjects: 60
Study 36060670 — intervention group
Group type: COMPARATOR
Intervention: Integrated medical and nursing rounds
Number of subjects: 60
Study 34627875 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenal mucosal resurfacing (DMR)
Number of subjects: 32
Study 34627875 — intervention group
Group type: COMPARATOR
Intervention: Sham endoscopy
Number of subjects: 32
Study 36059130 — intervention group
Group type: COMPARATOR
Intervention: Rilpivirine-based ART
Number of subjects: 0
Study 36059130 — intervention group
Group type: COMPARATOR
Intervention: Darunavir-based ART
Number of subjects: 0
Study 36059130 — intervention group
Group type: COMPARATOR
Intervention: Etonogestrel and Levonorgestrel implants
Number of subjects: 0
Study 34386816 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable Intervention (VI) - participants received extra vegetables (≥270 g/d)
Number of subjects: 102
Study 34386816 — intervention group
Group type: COMPARATOR
Intervention: Attention Control (CON) - conducted only the testing visits
Number of subjects: 102
Study 35284550 — intervention group
Group type: EXPERIMENTAL
Intervention: Defect management improvement mode based on the JCI standard
Number of subjects: 32
Study 35284550 — intervention group
Group type: COMPARATOR
Intervention: Standardized management mode
Number of subjects: 32
Study 32393405 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental condition (reading a scientific abstract on the importance of thought control)
Number of subjects: 85
Study 32393405 — intervention group
Group type: COMPARATOR
Intervention: Control condition (reading a neutral abstract)
Number of subjects: 85
Study 35960009 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted modified radical hysterectomy with removal of lymphatic vessels (RLV) using indocyanine green (ICG)
Number of subjects: 34
Study 35960009 — intervention group
Group type: COMPARATOR
Intervention: Robot-assisted modified radical hysterectomy without removal of lymphatic vessels (RLV)
Number of subjects: 34
Study 34747338 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogenic fecal microbiota transplant (FMT)
Number of subjects: 0